Evidence map›Paper›PMID 18174779›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2008

The importance of prompt blood pressure control.

Jan Basile

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00126750 (MI-Plus), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00126750 nacompletednot on this map

MI-Plus: Web-enhanced Guideline Implementation for Post MI CBOC Patients

TypeinterventionalSponsorUS Department of Veterans AffairsRan2003 to 2010Enrolled847ConditionsMyocardial Infarction, ComorbidityArmsVA MI Plus Interactive
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  2. Review
  3. Current challenges in the clinical management of hypertension.Nature reviews. Cardiology · 2011 · on this map
    Review
  4. The clock is ticking: the case for achieving more rapid control of hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2010
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jan BasilePrimary Care Service Line, Ralph H. Johnson, VA Medical Center, Charleston, SC 29403, USA. jan.basile@va.gov

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension affects almost one-third of adults in the United States, but blood pressure is adequately controlled in only about 50% to 60% of persons with treated hypertension. Abundant clinical trial evidence has shown that antihypertensive therapy significantly reduces the risk of vascular events, and meta-analyses of observational and clinical trials have shown that greater reductions in blood pressure are associated with greater reductions in risk. Recent trials have also suggested that prompt control of blood pressure is beneficial in high-risk patients with hypertension. A post hoc analysis of a trial comparing an angiotensin II receptor blocker-based program with a calcium channel blocker-based treatment regimen found that the blood pressure response after 1 month (regardless of the drug used) predicted the risk of vascular events and survival. Therapy with > or =2 medications given separately or as a fixed combination is more likely than monotherapy to lower blood pressure to goal in part because drugs from different classes target different mechanisms that regulate blood pressure. Moreover, the likelihood of achieving blood pressure goals is greater if the time to achieve control is shortened, and prompt control of blood pressure is more likely with multiple-drug therapy than with monotherapy.

Indexed as

Drug Therapy, CombinationAntihypertensive AgentsBlood PressureCardiovascular DiseasesDiureticsDrug CombinationsHumansHypertensionRandomized Controlled Trials as TopicRisk FactorsTime FactorsAntihypertensive AgentsDiureticsDrug Combinations

Identifiers

PMID18174779
PMCPMC8110160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.